泓博医药 (301230.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(泓博医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 130,725,745.26489,717,074.89367,212,523.37237,655,059.97121,392,447.24478,883,784.02332,128,900.74205,867,164.68104,314,490.66
 营业利润(元) 1,764,717.0237,444,320.6249,494,909.7536,771,258.4117,368,077.1472,845,278.6842,018,520.5423,273,435.4211,641,963.74
 利润总额(元) 1,857,877.5036,762,779.7748,999,641.3336,498,427.8617,237,207.5672,921,522.9942,150,311.8523,299,998.7311,701,557.15
 净利润(元) 3,667,660.5637,619,249.0945,934,017.7232,888,192.7615,275,796.3567,175,882.4538,173,281.7220,521,419.6610,389,651.14
 归属于母公司股东的净利润(元) 3,667,660.5637,619,249.0945,934,017.7232,888,192.7615,275,796.3567,175,882.4538,173,281.7220,521,419.6610,389,651.14
盈利能力:
 销售毛利率(%) 20.6130.8834.6137.1635.8136.8736.1337.7936.25
 销售净利率(%) 2.817.6812.5113.8412.5814.0311.499.979.96
 净资产收益率(%) 0.333.376.044.422.05----
 总资产报酬率ROA(%) 0.172.594.483.481.87----
 投入资本回报率ROIC(%) 0.323.273.962.871.338.749.275.112.18
营运能力:
 存货周转率(次) 1.656.023.622.122.27----
 应收账款周转率(次) 1.455.844.503.313.02----
 总资产周转率(次) 0.090.350.360.250.13----
偿债能力:
 资产负债率(%) 23.9624.8524.0918.6713.2914.4830.1431.2335.46
 股东权益比率(%) 76.0475.1575.9181.3386.7185.5269.8668.7764.54
 已获利息倍数(倍) 5.09-61.89-14.60-10.4474.14-8.88-4.98-4.677.69
 流动比率 3.963.824.637.9210.259.282.832.71-
 速动比率 2.772.683.225.648.018.051.051.50-
发展能力:
 营业收入增长率(%) 7.692.2610.5615.4416.376.8412.588.67-
 营业利润增长率(%) -89.84-48.6017.7958.0049.19-15.95-11.40-13.20-14.34
 税后利润增长率(%) -75.99-44.0020.3360.2647.03-8.70-4.72-8.70-6.81
 净资产增长率(%) -2.450.42184.88197.01212.70219.39-28.63-
 总资产增长率(%) 11.2414.29162.21151.14132.75133.28-29.71-

前瞻产业研究院